Jinming Yu

845 total citations
33 papers, 627 citations indexed

About

Jinming Yu is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Radiation. According to data from OpenAlex, Jinming Yu has authored 33 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 21 papers in Radiology, Nuclear Medicine and Imaging and 12 papers in Radiation. Recurrent topics in Jinming Yu's work include Lung Cancer Diagnosis and Treatment (26 papers), Radiomics and Machine Learning in Medical Imaging (15 papers) and Medical Imaging Techniques and Applications (12 papers). Jinming Yu is often cited by papers focused on Lung Cancer Diagnosis and Treatment (26 papers), Radiomics and Machine Learning in Medical Imaging (15 papers) and Medical Imaging Techniques and Applications (12 papers). Jinming Yu collaborates with scholars based in China, United States and South Korea. Jinming Yu's co-authors include Xiaorong Sun, Ligang Xing, Jing Liu, Wen‐Wu Li, Min Dong, Xindong Sun, Xiuyi Zhi, Zheng Fu, Yuankai Shi and Ligang Xing and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Jinming Yu

29 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinming Yu China 13 408 400 136 102 40 33 627
Aidan Cole United Kingdom 15 316 0.8× 302 0.8× 176 1.3× 78 0.8× 32 0.8× 47 548
Ronald Shapiro United States 9 328 0.8× 163 0.4× 233 1.7× 69 0.7× 44 1.1× 17 455
Wilma Uyterlinde Netherlands 10 350 0.9× 175 0.4× 137 1.0× 177 1.7× 21 0.5× 24 507
S. Hominal France 9 340 0.8× 134 0.3× 109 0.8× 134 1.3× 102 2.5× 27 422
Matthew B. Lipner United States 5 258 0.6× 199 0.5× 142 1.0× 105 1.0× 34 0.8× 7 452
Shi‐Xiong Liang China 15 376 0.9× 252 0.6× 227 1.7× 177 1.7× 68 1.7× 47 915
Jun Dang China 15 344 0.8× 141 0.4× 94 0.7× 220 2.2× 31 0.8× 43 497
Federica Fioroni Italy 16 207 0.5× 602 1.5× 162 1.2× 148 1.5× 20 0.5× 45 819
Cinzia Digesù Italy 15 500 1.2× 258 0.6× 463 3.4× 94 0.9× 92 2.3× 45 796
Nakashi Sasano Japan 12 292 0.7× 134 0.3× 176 1.3× 65 0.6× 16 0.4× 14 483

Countries citing papers authored by Jinming Yu

Since Specialization
Citations

This map shows the geographic impact of Jinming Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinming Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinming Yu more than expected).

Fields of papers citing papers by Jinming Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinming Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinming Yu. The network helps show where Jinming Yu may publish in the future.

Co-authorship network of co-authors of Jinming Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Jinming Yu. A scholar is included among the top collaborators of Jinming Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinming Yu. Jinming Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
3.
Wang, Kaiyue, Jiarui Zhao, Haiyan Zhou, et al.. (2024). Neoadjuvant camrelizumab combined with chemotherapy for resectable stage IIIA-IIIb non-small cell lung cancer: Single arm phase II study.. Journal of Clinical Oncology. 42(16_suppl). e20074–e20074.
4.
Chen, Yu, Jinming Yu, & Xiangjiao Meng. (2023). Postoperative Radiotherapy in Completely Resected IIIA-N2 Non-small Cell Lung Cancer: Quit or Not?. The Oncologist. 28(5). 376–378.
5.
Li, Li, Wei Zhao, Xiaorong Sun, et al.. (2020). 18F-RGD PET/CT imaging reveals characteristics of angiogenesis in non-small cell lung cancer. Translational Lung Cancer Research. 9(4). 1324–1332. 18 indexed citations
6.
Yu, Jinming, Xue Meng, Lingfei Liu, et al.. (2020). The feasibility of non-contrast enhanced plus contrast-enhanced computed tomography in discriminating invasive pure ground-glass opacity from pre-invasive pure ground-glass opacity. Journal of Cardiothoracic Surgery. 15(1). 162–162. 1 indexed citations
7.
Zhu, Ying, Lei Fu, Jing Wang, Li Kong, & Jinming Yu. (2019). <p>Radiotherapy for patients with completely resected pathologic IIIA(N2) non–small-cell lung cancer: a retrospective analysis</p>. Cancer Management and Research. Volume 11. 10901–10908. 4 indexed citations
8.
Xiao, Linlin, Ning Liu, Guifang Zhang, et al.. (2017). Late-Course Adaptive Adjustment Based on Metabolic Tumor Volume Changes during Radiotherapy May Reduce Radiation Toxicity in Patients with Non-Small Cell Lung Cancer. PLoS ONE. 12(1). e0170901–e0170901. 17 indexed citations
9.
Liu, Jing, Min Dong, Xiaorong Sun, et al.. (2016). Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis. PLoS ONE. 11(1). e0146195–e0146195. 147 indexed citations
11.
Zhao, Hanxi, Peng Xie, Xiaolin Li, et al.. (2015). A prospective phase II trial of EGCG in treatment of acute radiation-induced esophagitis for stage III lung cancer. Radiotherapy and Oncology. 114(3). 351–356. 57 indexed citations
12.
Gao, Ang, et al.. (2015). (18)F-FDG avid volumes on pre-radiotherapy FDG PET as boost target delineation in non-small cell lung cancer.. PubMed. 8(5). 7561–8. 4 indexed citations
13.
Zhao, Fen, Yunfeng Cui, Minghuan Li, et al.. (2014). Prognostic value of 3′-Deoxy-3′-18F-Fluorothymidine ([18F] FLT PET) in patients with recurrent malignant gliomas. Nuclear Medicine and Biology. 41(8). 710–715. 18 indexed citations
14.
Sun, Xindong, et al.. (2014). PET/CT imaging-guided dose painting in radiation therapy. Cancer Letters. 355(2). 169–175. 21 indexed citations
15.
Frey, Kirk A., et al.. (2014). Changes in Functional Lung Regions During the Course of Radiation Therapy and Their Potential Impact on Lung Dosimetry for Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 89(1). 145–151. 35 indexed citations
16.
Yu, Jinming, Boram Lee, Sunmi Ju, et al.. (2011). Proportion and characteristics of transient nodules in a retrospective analysis of pulmonary nodules. Thoracic Cancer. 3(3). 224–228. 8 indexed citations
17.
Li, X., et al.. (2011). Mediastinal Lymph Nodes Staging By 18F-FDG PET/CT For Early-stage Non-small Cell Lung Cancer: A Multicenter Study. International Journal of Radiation Oncology*Biology*Physics. 81(2). S600–S600. 4 indexed citations
19.
Yu, Jinming, Ligang Xing, Dianbin Mu, et al.. (2009). Comparison of Tumor Volumes as Determined by Pathologic Examination and FDG-PET/CT Images of Non–Small-Cell Lung Cancer: A Pilot Study. International Journal of Radiation Oncology*Biology*Physics. 75(5). 1468–1474. 53 indexed citations
20.
Yang, Wenfeng, Zheng Fu, Jinming Yu, et al.. (2008). Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer. Lung Cancer. 61(1). 35–43. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026